However, high or positive OX-40 expression in tumor-infiltrating ICs is correlated with improved survival in cutaneous malignant melanoma, colorectal cancer, glioblastoma, non-small cell lung cancer, gastric cancer, and ovarian cancer (30–36). The gene discussed is TNFRSF4; the disease is non-small cell lung carcinoma.